Medtronic (MDT) Non Operating Interest Expenses (2014 - 2026)

Medtronic has disclosed Non Operating Interest Expenses across 13 years of filings, most recently posting $186.0 million for Q3 2026.

• In Q3 2026, Non Operating Interest Expenses rose 5.68% year-over-year to $186.0 million; the TTM figure through Jul 2026 stood at $724.0 million (down 1.9% YoY), while the FY2026 annual figure was $715.0 million, down 1.92% from the prior year.
• Non Operating Interest Expenses came in at $186.0 million for Q3 2026 at Medtronic, up from $176.0 million in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $209.0 million in Q4 2024 to a low of $118.0 million in Q4 2022.
• Average Non Operating Interest Expenses over 5 years is $171.7 million, with a median of $176.0 million recorded in 2025.
• Year-over-year, Non Operating Interest Expenses surged 52.54% in 2023 and dropped 13.86% in 2025.
• Over 5 years, Non Operating Interest Expenses stood at $118.0 million in 2022, then jumped by 52.54% to $180.0 million in 2023, then increased by 16.11% to $209.0 million in 2024, then declined by 13.4% to $181.0 million in 2025, then rose by 2.76% to $186.0 million in 2026.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $186.0 million in Q3 2026, $176.0 million in Q2 2026, and $181.0 million in Q1 2026.